Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank Network Comparison Type Value Type green Interaction Map description network_comparison red Filtered
Results: HTML CSV LaTeX Showing element 2025 to 2074 of 3228 in total
Network Comparison Type  : Divided
Value Type  : Ranked
Interaction Map  : High confidence
Filtered  : 1
Rank
green
description
network_comparison
red
2025 191.668 alanine aminotransferase (ec 2.6.1.2) (glutamic--pyruvic transaminase) (gpt) (glutamic--alanine transaminase). [swissprot;acc:p24298] 1.00885 189.987
2026 213.663 vacuolar protein sorting 11 (hvps11) (pp3476). [swissprot;acc:q9h270] 215.553
2027 223.041 lin-7 homolog c; lin-7 protein 3. [refseq;acc:nm_018362] 225.015
2028 213.663 vacuolar protein sorting 33a (hvps33a). [swissprot;acc:q96ax1] 215.553
2029 191.677 cytoplasmic cysteine conjugate-beta lyase; glutamine-phenylpyruvate aminotransferase. [refseq;acc:nm_004059] 1.00883 189.999
2030 alanine aminotransferase 2; glutamic-pyruvate transaminase 2. [refseq;acc:nm_133443]
2031 216.562 traf and tnf receptor-associated protein; ets1-associated protein 2. [refseq;acc:nm_016614] 1.00879 218.466
2032 213.46 f-actin capping protein alpha-3 subunit (capz alpha-3) (germ cell- specific protein 3). [swissprot;acc:q96kx2] 1.00872 215.322
2033 f-actin capping protein beta subunit (capz beta). [swissprot;acc:p47756]
2034 220.812 centaurin beta 5 (cnt-b5). [swissprot;acc:q96p50] 1.00865 218.919
2035 centaurin beta 2 (cnt-b2). [swissprot;acc:q15057]
2036 220.813 lamin b1. [swissprot;acc:p20700]
2037 220.812 centaurin beta 1 (cnt-b1). [swissprot;acc:q15027]
2038 220.811 lamin a/c (70 kda lamin). [swissprot;acc:p02545] 1.00864 218.92
2039 192.191 acetyl-coenzyme a synthetase, cytoplasmic (ec 6.2.1.1) (acetate--coa ligase) (acyl-activating enzyme) (acetyl-coa synthetase) (acs) (acecs). [swissprot;acc:q9nr19] 1.00861 190.551
2040 208.803 brachyury protein (t protein). [swissprot;acc:o15178] 1.00854 210.586
2041 195.141 ataxin-1 ubiquitin-like interacting protein. [refseq;acc:nm_020131] 196.808
2042 208.803 t-box transcription factor tbx19 (t-box protein 19). [swissprot;acc:o60806] 210.586
2043 195.173 ubiquilin 1 isoform 1. [refseq;acc:nm_013438] 1.00853 196.837
2044 198.24 adapter-related protein complex 3 beta 1 subunit (beta-adaptin 3a) (ap-3 complex beta-3a subunit) (beta-3a-adaptin). [swissprot;acc:o00203] 1.00851 199.928
2045 ny-ren-24 antigen (fragment). [sptrembl;acc:q9y5a4]
2046 adapter-related protein complex 3 beta 2 subunit (beta-adaptin 3b) (ap-3 complex beta-3b subunit) (beta-3b-adaptin) (neuron-specific vesicle coat protein beta-nap). [swissprot;acc:q13367]
2047 226.003 solute carrier family 2, facilitated glucose transporter, member 6 (glucose transporter type 6) (glucose transporter type 9). [swissprot;acc:q9ugq3] 1.00838 224.124
2048 solute carrier family 2, facilitated glucose transporter, member 8 (glucose transporter type 8) (glucose transporter type x1). [swissprot;acc:q9ny64]
2049 222.634 translation initiation factor eif-2b beta subunit (eif-2b gdp-gtp exchange factor) (s20i15) (s20iii15). [swissprot;acc:p49770] 1.00837 220.787
2050 216.981 sh3 domain-binding glutamic acid-rich protein (sh3bgr protein) (21- glutamic acid-rich protein) (21-garp). [swissprot;acc:p55822] 1.00834 218.79
2051 oxidation resistance 1. [refseq;acc:nm_181354]
2052 205.95 ornithine decarboxylase antizyme inhibitor. [swissprot;acc:o14977] 207.667
2053 216.981 lats, large tumor suppressor, homolog 2; lats (large tumor suppressor, drosophila) homolog 2. [refseq;acc:nm_014572] 218.79
2054 205.948 ornithine decarboxylase-like protein (ec 4.1.1.17) (odc-paralogue) (odc-p). [swissprot;acc:q96a70] 207.665
2055 216.981 dymeclin. [refseq;acc:nm_017653] 218.79
2056 sh3 domain-binding glutamic acid-rich-like protein. [swissprot;acc:o75368]
2057 lats homolog 1. [refseq;acc:nm_004690]
2058 sh3 domain-binding glutamic acid-rich-like protein 2 (fovea-associated sh3 domain binding protein). [swissprot;acc:q9ujc5]
2059 nuclear receptor coactivator 7; estrogen receptor associated protein 140 kda. [refseq;acc:nm_181782]
2060 dj132f21.2 (contains a novel protein similar to the l82e from drosophila) (fragment). [sptrembl;acc:q9h125]
2061 tbc1 domain family protein c22orf4-like (fragment). [swissprot;acc:q9nu19]
2062 tbc1 domain family protein c22orf4. [swissprot;acc:q8wua7]
2063 205.923 ornithine decarboxylase (ec 4.1.1.17) (odc). [swissprot;acc:p11926] 1.00833 207.638
2064 205.939 aminoadipate-semialdehyde synthase; lysine-ketoglutarate reductase /saccharopine dehydrogenase; lysine-2-oxoglutarate reductase; aminoadipic semialdehyde synthase. [refseq;acc:nm_005763] 207.655
2065 212.561 ubiquitin-conjugating enzyme e2 n (ec 6.3.2.19) (ubiquitin-protein ligase n) (ubiquitin carrier protein n) (ubc13) (bendless-like ubiquitin conjugating enzyme). [swissprot;acc:q16781] 1.00831 214.328
2066 231.001 proliferating cell nuclear antigen (pcna) (cyclin). [swissprot;acc:p12004] 1.00829 229.102
2067 191.639 adenylosuccinate lyase (ec 4.3.2.2) (adenylosuccinase) (asl) (asase). [swissprot;acc:p30566] 1.00828 193.226
2068 222.61 fas apoptotic inhibitory molecule. [refseq;acc:nm_018147] 1.0082 220.8
2069 215.807 dual specificity mitogen-activated protein kinase kinase 1 (ec 2.7.1.-) (map kinase kinase 1) (mapkk 1) (erk activator kinase 1) (mapk/erk kinase 1) (mek1). [swissprot;acc:q02750] 1.0081 217.555
2070 225.008 rac gtpase activating protein 1; gtpase activating protein. [refseq;acc:nm_013277] 223.199
2071 215.807 similar to kinase suppressor of ras (fragment). [sptrembl;acc:q8ivt5] 217.555
2072 dual specificity mitogen-activated protein kinase kinase 2 (ec 2.7.1.-) (map kinase kinase 2) (mapkk 2) (erk activator kinase 2) (mapk/erk kinase 2) (mek2). [swissprot;acc:p36507]
2073 227.433 topoisomerase-related function protein 4-2. [refseq;acc:nm_022447] 1.00806 229.267
2074 214.599 dna polymerase gamma subunit 1 (ec 2.7.7.7) (mitochondrial dna polymerase catalytic subunit) (polg-alpha). [swissprot;acc:p54098] 1.00804 216.324

Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/